Aunt Minnie (7/24, Yee) reports that according to a study published online July 20 in the Journal of the American College of Radiology, “factors associated with radiologists – such as their annual reading volume and experience – can affect breast cancer screening recall rates just as much as patient characteristics such as age or breast tissue density.” The findings “suggest that particular interventions that target radiologists – such as boosting annual reading volume requirements or performing second reviews of potential recalls – could help reduce unwanted variation in recall rates.”
The Radiology Business Journal (7/24, Slachta) reports that Nicole Saphier, MD, “a New Jersey-based radiologist, has been selected for the CDC’s Advisory Committee on Breast Cancer in Young Women, the American College of Radiology announced this week.”
HealthImaging (7/24, Rohman) reports that research suggests “screening mammography recall rates may be associated with a radiologist’s annual reading volume and level of experience.” The research “also demonstrated no direct correlation between higher radiologist recall rates and increased cancer detection among breast subspecialists.” The findings were published in the Journal of the American College of Radiology.
The Radiology Business Journal (7/24, Slachta) reports that the FDA has “approved the American College of Radiology (ACR)’s proposed amendment to incorporate information about digital breast tomosynthesis (DBT) into its 2016 Digital Mammography Quality Control Manual, which would give physicians a uniform set of quality control guidelines instead of different manufacturers’ QC requirements.”
HealthImaging (7/24, O'Connor) reports that Eric Berns, PhD, lead chair of the ACR Subcommittee on Mammography Quality Assurance, said, “The new DBT QC procedures in the updated ACR manual will promote uniformity of quality control since it will allow facilities to follow one manual, instead of the dozens of different manuals that are mandated for the varying manufacturers and models of digital mammography equipment with DBT.” Berns added, “The new manual focuses on tests that are clinically relevant for high-quality imaging and provides the structure for a thorough and complete quality control program.”
MedPage Today (7/20, Ingram) reported that an analysis indicated “a polymorphism can identify breast cancer patients who are at higher risk for developing high-grade radiation-induced fibrosis.” Researchers found that “in women with a C-509T variant allele of the TGFB1 gene, 13.8% developed grade 2 or higher breast fibrosis following radiation therapy, compared with 3.8% of those not carrying the marker.” The findings were published in JAMA Oncology.